GlassScriptPhysician profile
Kellie R Satterfield
NPI 1629509336
$76,270.24
in general payments reported to CMS, 2019-2025
14 companies · $74K in 2025
The $74K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $13.39 · 2023: $247 · 2024: $1,823 · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Travel and Lodging: $8,306 · Food and Beverage: $4,708 · Consulting Fee: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,762.50 |
| Travel and Lodging | $8,306.33 |
| Food and Beverage | $4,708.40 |
| Consulting Fee | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $74,140.11 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $885.25 | 2024-2025 | Omni Surgical System |
| Alcon Vision LLC | $353.99 | 2023-2025 | Hydrus Microstent, Unity |
| Amgen INC. | $245.33 | 2024 | Tepezza |
| Abbvie INC. | $153.85 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $140.62 | 2023-2025 | Miebo, Xiidra |
| Horizon Therapeutics Plc | $119.94 | 2021-2023 | Tepezza |
| Motiva USA, LLC | $69.75 | 2025 | |
| Revance Therapeutics, INC. | $44.52 | 2024 | Daxxify |
| Merz North America, INC. | $34.47 | 2021 | |
| Tela Bio, INC. | $23.27 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Thea Pharma INC. | $23.14 | 2025 | Iyuzeh |
| Musculoskeletal Transplant Foundation INC. | $22.61 | 2025 | |
| Oyster Point Pharma, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Satterfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.